ORIGINAL RESEARCH article

Front. Physiol., 01 April 2021

Sec. Mitochondrial Research

Volume 12 - 2021 | https://doi.org/10.3389/fphys.2021.646903

This article is part of the Research TopicRole of Mitochondrial Quality Control in Myocardial and Microvascular Physiology and PathophysiologyView all 43 articles

RETRACTED: MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway

Retracted

A retraction of this article was approved in:

  1. Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway

    1. Read retraction
Runze Wang,&#x;Runze Wang1,2†Yuerong Xu&#x;Yuerong Xu3†Xiaolin Niu&#x;Xiaolin Niu1†Yexian FangYexian Fang1Dong GuoDong Guo1Jiangwei ChenJiangwei Chen4Hanzhao ZhuHanzhao Zhu5Jiaying DongJiaying Dong1Ran ZhaoRan Zhao1Ying WangYing Wang1Bingchao QiBingchao Qi1Gaotong RenGaotong Ren1Xue Li Xue Li1*Li Liu Li Liu2*Mingming Zhang Mingming Zhang1*
  • 1Department of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
  • 2Department of Hematology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China
  • 3Department of Orthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, China
  • 4Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China
  • 5Department of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang R, Xu Y, Niu X, Fang Y, Guo D, Chen J, Zhu H, Dong J, Zhao R, Wang Y, Qi B, Ren G, Li X, Liu L and Zhang M (2021) MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway. Front. Physiol. 12:646903. doi: 10.3389/fphys.2021.646903

Received: 28 December 2020; Accepted: 22 February 2021;
Published: 01 April 2021; Retracted: 24 August 2022.

Edited by:

Hao Zhou, People's Liberation Army General Hospital, China

Reviewed by:

Liping Wei, Nankai University, China
Ying Tan, Southern Medical University, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more